{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T09:08:37Z","timestamp":1716800917473},"reference-count":30,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,10]]},"DOI":"10.7759\/cureus.30159","type":"journal-article","created":{"date-parts":[[2022,10,11]],"date-time":"2022-10-11T06:34:11Z","timestamp":1665470051000},"source":"Crossref","is-referenced-by-count":1,"title":["Predictors of Definitive Treatment Interruptions of Long-Course Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer"],"prefix":"10.7759","author":[{"given":"Lucas G","family":"Sapienza","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sreejata","family":"Raychaudhuri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suraya K","family":"Nahlawi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serene","family":"Ozeir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eyad","family":"Abu-Isa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa040694","article-title":"Preoperative versus postoperative chemoradiotherapy for rectal cancer","volume":"351","author":"Sauer R","year":"2004","unstructured":"Sauer R, Becker H, Hohenberger W, et al.. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004, 351:1731-40. 10.1056\/NEJMoa040694","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2011.40.1836","article-title":"Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years","volume":"30","author":"Sauer R","year":"2012","unstructured":"Sauer R, Liersch T, Merkel S, et al.. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO\/ARO\/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol. 2012, 30:1926-33. 10.1200\/JCO.2011.40.1836","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.22.0467","article-title":"Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03","volume":"27","author":"Roh MS","year":"2009","unstructured":"Roh MS, Colangelo LH, O'Connell MJ, et al.. Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol. 2009, 27:5124-30. 10.1200\/JCO.2009.22.0467","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1318.2011.02815.x","article-title":"Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery","volume":"14","author":"Latkauskas T","year":"2012","unstructured":"Latkauskas T, Pauzas H, Gineikiene I, et al.. Initial results of a randomized controlled trial comparing clinical and pathological downstaging of rectal cancer after preoperative short-course radiotherapy or long-term chemoradiotherapy, both with delayed surgery. Colorectal Dis. 2012, 14:294-8. 10.1111\/j.1463-1318.2011.02815.x","journal-title":"Colorectal Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.03.014","article-title":"Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer","volume":"44","author":"Hoendervangers S","year":"2018","unstructured":"Hoendervangers S, Couwenberg AM, Intven MP, van Grevenstein WM, Verkooijen HM. Comparison of pathological complete response rates after neoadjuvant short-course radiotherapy or chemoradiation followed by delayed surgery in locally advanced rectal cancer. Eur J Surg Oncol. 2018, 44:1013-7. 10.1016\/j.ejso.2018.03.014","journal-title":"Eur J Surg Oncol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2018.03.017","article-title":"Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients","volume":"44","author":"Rombouts AJ","year":"2018","unstructured":"Rombouts AJ, Hugen N, Verhoeven RH, Elferink MA, Poortmans PM, Nagtegaal ID, de Wilt JH. Tumor response after long interval comparing 5x5Gy radiation therapy with chemoradiation therapy in rectal cancer patients. Eur J Surg Oncol. 2018, 44:1018-24. 10.1016\/j.ejso.2018.03.017","journal-title":"Eur J Surg Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.4911","article-title":"Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial","volume":"29","author":"Aschele C","year":"2011","unstructured":"Aschele C, Cionini L, Lonardi S, et al.. Primary tumor response to preoperative chemoradiation with or without oxaliplatin in locally advanced rectal cancer: pathologic results of the STAR-01 randomized phase III trial. J Clin Oncol. 2011, 29:2773-80. 10.1200\/JCO.2010.34.4911","journal-title":"J Clin Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000001987","article-title":"Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma of the rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04)","volume":"265","author":"Ansari N","year":"2017","unstructured":"Ansari N, Solomon MJ, Fisher RJ, et al.. Acute adverse events and postoperative complications in a randomized trial of preoperative short-course radiotherapy versus long-course chemoradiotherapy for T3 adenocarcinoma of the rectum: Trans-Tasman Radiation Oncology Group Trial (TROG 01.04). Ann Surg. 2017, 265:882-8. 10.1097\/SLA.0000000000001987","journal-title":"Ann Surg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(12)70187-0","article-title":"Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial","volume":"13","author":"R\u00f6del C","year":"2012","unstructured":"R\u00f6del C, Liersch T, Becker H, et al.. Preoperative chemoradiotherapy and postoperative chemotherapy with fluorouracil and oxaliplatin versus fluorouracil alone in locally advanced rectal cancer: initial results of the German CAO\/ARO\/AIO-04 randomised phase 3 trial. Lancet Oncol. 2012, 13:679-87. 10.1016\/S1470-2045(12)70187-0","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-489752\/v1","article-title":"Clinical predictors of definitive treatment interruptions of long-course neoadjuvant chemoradiotherapy in locally advanced rectal cancer [PREPRINT]","author":"Sapienza LG","year":"2021","unstructured":"Sapienza LG, Raychaudhuri S, Nahlawi SK, Ozeir S, Abu-Isa E. Clinical predictors of definitive treatment interruptions of long-course neoadjuvant chemoradiotherapy in locally advanced rectal cancer [PREPRINT]. ResearchSquare.  2021, 10.21203\/rs.3.rs-489752\/v1","journal-title":"ResearchSquare"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/BF02605754","article-title":"The length of the anal canal","volume":"24","author":"Nivatvongs S","year":"1981","unstructured":"Nivatvongs S, Stern HS, Fryd DS. The length of the anal canal. Dis Colon Rectum. 1981, 24:600-1. 10.1007\/BF02605754","journal-title":"Dis Colon Rectum"},{"key":"ref12","unstructured":"U.S. Department of Health and Human Services - National Institutes of Health. Common terminology criteria for adverse events v4.0 (CTCAE). (2020032021). https:\/\/www.eortc.be\/services\/doc\/ctc\/ctcae_4.03_2010-06-14_quickreference_5x7.pdf."},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1958.10501452","article-title":"Nonparametric estimation from incomplete observations","volume":"53","author":"Kaplan EL","year":"1958","unstructured":"Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958, 53:457-81. 10.1080\/01621459.1958.10501452","journal-title":"J Am Stat Assoc"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.09.036","article-title":"Small bowel dose parameters predicting grade \u2265 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques","volume":"85","author":"Banerjee R","year":"2013","unstructured":"Banerjee R, Chakraborty S, Nygren I, Sinha R. Small bowel dose parameters predicting grade \u2265 3 acute toxicity in rectal cancer patients treated with neoadjuvant chemoradiation: an independent validation study comparing peritoneal space versus small bowel loop contouring techniques. Int J Radiat Oncol Biol Phys. 2013, 85:1225-31. 10.1016\/j.ijrobp.2012.09.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.05.071","article-title":"Radiation dose-volume effects in the stomach and small bowel","volume":"76","author":"Kavanagh BD","year":"2010","unstructured":"Kavanagh BD, Pan CC, Dawson LA, Das SK, Li XA, Ten Haken RK, Miften M. Radiation dose-volume effects in the stomach and small bowel. Int J Radiat Oncol Biol Phys. 2010, 76:S101-7. 10.1016\/j.ijrobp.2009.05.071","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-19-0960","article-title":"Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late-radiation enteropathy","volume":"25","author":"Reis Ferreira M","year":"2019","unstructured":"Reis Ferreira M, Andreyev HJ, Mohammed K, et al.. Microbiota- and radiotherapy-induced gastrointestinal side-effects (MARS) study: a large pilot study of the microbiome in acute and late-radiation enteropathy. Clin Cancer Res. 2019, 25:6487-500. 10.1158\/1078-0432.CCR-19-0960","journal-title":"Clin Cancer Res"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2019.12.040","article-title":"Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer","volume":"107","author":"Mitra A","year":"2020","unstructured":"Mitra A, Grossman Biegert GW, Delgado AY, et al.. Microbial diversity and composition is associated with patient-reported toxicity during chemoradiation therapy for cervical cancer. Int J Radiat Oncol Biol Phys. 2020, 107:163-71. 10.1016\/j.ijrobp.2019.12.040","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.08.012","article-title":"Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival","volume":"64","author":"Wiltshire KL","year":"2006","unstructured":"Wiltshire KL, Ward IG, Swallow C, et al.. Preoperative radiation with concurrent chemotherapy for resectable rectal cancer: effect of dose escalation on pathologic complete response, local recurrence-free survival, disease-free survival, and overall survival. Int J Radiat Oncol Biol Phys. 2006, 64:709-16. 10.1016\/j.ijrobp.2005.08.012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.02.006","article-title":"Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses","volume":"84","author":"Jakobsen A","year":"2012","unstructured":"Jakobsen A, Ploen J, Vuong T, Appelt A, Lindebjerg J, Rafaelsen SR. Dose-effect relationship in chemoradiotherapy for locally advanced rectal cancer: a randomized trial comparing two radiation doses. Int J Radiat Oncol Biol Phys. 2012, 84:949-54. 10.1016\/j.ijrobp.2012.02.006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2020.06.013","article-title":"Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): a phase 2 randomized controlled trial","volume":"108","author":"Couwenberg AM","year":"2020","unstructured":"Couwenberg AM, Burbach JP, Berbee M, et al.. Efficacy of dose-escalated chemoradiation on complete tumor response in patients with locally advanced rectal cancer (RECTAL-BOOST): a phase 2 randomized controlled trial. Int J Radiat Oncol Biol Phys. 2020, 108:1008-18. 10.1016\/j.ijrobp.2020.06.013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(17)30086-4","article-title":"Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial","volume":"18","author":"Erlandsson J","year":"2017","unstructured":"Erlandsson J, Holm T, Pettersson D, et al.. Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial. Lancet Oncol. 2017, 18:336-46. 10.1016\/S1470-2045(17)30086-4","journal-title":"Lancet Oncol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.suronc.2012.11.001","article-title":"Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications","volume":"22","author":"Mirnezami R","year":"2013","unstructured":"Mirnezami R, Chang GJ, Das P, Chandrakumaran K, Tekkis P, Darzi A, Mirnezami AH. Intraoperative radiotherapy in colorectal cancer: systematic review and meta-analysis of techniques, long-term outcomes, and complications. Surg Oncol. 2013, 22:22-35. 10.1016\/j.suronc.2012.11.001","journal-title":"Surg Oncol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.21037\/jgo.2015.11.03","article-title":"Post operative stereotactic radiosurgery for positive or close margins after preoperative chemoradiation and surgery for rectal cancer","volume":"7","author":"Dagoglu N","year":"2016","unstructured":"Dagoglu N, Nedea E, Poylin V, Nagle D, Mahadevan A. Post operative stereotactic radiosurgery for positive or close margins after preoperative chemoradiation and surgery for rectal cancer. J Gastrointest Oncol. 2016, 7:315-20. 10.21037\/jgo.2015.11.03","journal-title":"J Gastrointest Oncol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001855","article-title":"Persistent high rate of positive margins and postoperative complications after surgery for cT4 rectal cancer at a national level","volume":"64","author":"de Nes LC","year":"2021","unstructured":"de Nes LC, Drager LD, Verstegen MG, Burger JW, Tanis PJ, de Wilt JH. Persistent high rate of positive margins and postoperative complications after surgery for cT4 rectal cancer at a national level. Dis Colon Rectum. 2021, 64:389-98. 10.1097\/DCR.0000000000001855","journal-title":"Dis Colon Rectum"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.03.008","article-title":"Continuos effect of radial resection margin on recurrence and survival in rectal cancer patients who receive preoperative chemoradiation and curative surgery: a multi center retrospective analysis","volume":"98","author":"Sung S","year":"2017","unstructured":"Sung S, Kim SH, Lee JH, et al.. Continuos effect of radial resection margin on recurrence and survival in rectal cancer patients who receive preoperative chemoradiation and curative surgery: a multi center retrospective analysis. Int J Radiat Oncol Biol Phys. 2017, 98:647-53. 10.1016\/j.ijrobp.2017.03.008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000900","article-title":"A distal resection margin of \u22641mm and rectal cancer recurrence after sphincter-preserving surgery: the role of a positive distal margin in rectal cancer surgery","volume":"60","author":"Zeng WG","year":"2017","unstructured":"Zeng WG, Liu MJ, Zhou ZX, Wang ZJ. A distal resection margin of \u22641mm and rectal cancer recurrence after sphincter-preserving surgery: the role of a positive distal margin in rectal cancer surgery. Dis Colon Rectum. 2017, 60:1175-83. 10.1097\/DCR.0000000000000900","journal-title":"Dis Colon Rectum"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2005.09.017","article-title":"Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study","volume":"64","author":"Valentini V","year":"2006","unstructured":"Valentini V, Morganti AG, Gambacorta MA, et al.. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study. Int J Radiat Oncol Biol Phys. 2006, 64:1129-39. 10.1016\/j.ijrobp.2005.09.017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8541","article-title":"Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study","volume":"28","author":"Fern\u00e1ndez-Martos C","year":"2010","unstructured":"Fern\u00e1ndez-Martos C, Pericay C, Aparicio J, et al.. Phase II, randomized study of concomitant chemoradiotherapy followed by surgery and adjuvant capecitabine plus oxaliplatin (CAPOX) compared with induction CAPOX followed by concomitant chemoradiotherapy and surgery in magnetic resonance imaging-defined, locally advanced rectal cancer: Grupo cancer de recto 3 study. J Clin Oncol. 2010, 28:859-65. 10.1200\/JCO.2009.25.8541","journal-title":"J Clin Oncol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv223","article-title":"Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial\u2020","volume":"26","author":"Fernandez-Martos C","year":"2015","unstructured":"Fernandez-Martos C, Garcia-Albeniz X, Pericay C, et al.. Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial\u2020. Ann Oncol. 2015, 26:1722-8. 10.1093\/annonc\/mdv223","journal-title":"Ann Oncol"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00308","article-title":"Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12","volume":"37","author":"Fokas E","year":"2019","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, et al.. Randomized phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Clin Oncol. 2019, 37:3212-22. 10.1200\/JCO.19.00308","journal-title":"J Clin Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/116157-predictors-of-definitive-treatment-interruptions-of-long-course-neoadjuvant-chemoradiotherapy-in-locally-advanced-rectal-cancer","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:50:59Z","timestamp":1707508259000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/116157-predictors-of-definitive-treatment-interruptions-of-long-course-neoadjuvant-chemoradiotherapy-in-locally-advanced-rectal-cancer"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,10]]},"references-count":30,"URL":"https:\/\/doi.org\/10.7759\/cureus.30159","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10,10]]}}}